88191008 - ATGENGLOBAL

Information

  • Trademark
  • 88191008
  • Serial Number
    88191008
  • Filing Date
    November 12, 2018
    6 years ago
  • Transaction Date
    September 24, 2019
    5 years ago
  • Status Date
    September 24, 2019
    5 years ago
  • Location Date
    September 24, 2019
    5 years ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    MARTIN, EUGENIA K
  • Attorney Docket Number
    1114570
    Attorney Name
    MARGARET C. MCHUGH
    Law Office Assigned Location Code
    M50
  • Owners
Mark Drawing Code
4000
Mark Identification
ATGENGLOBAL
Case File Statements
  • GS0011: Proteins in raw material form for scientific and medical research; Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for use by others in manufacturing pharmaceutical and veterinary preparations; proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for scientific and research purposes; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA in disease diagnosis screening, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use
  • GS0051: Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones for veterinary or medical purposes: hormones; diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use
  • GS0351: Online retail store services featuring proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; online retail store services featuring vitro diagnostic devices and antibody detection kits
  • GS0401: Custom manufacture of proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; Custom manufacture of in vitro diagnostic devices and antibody detection kits
  • GS0421: medical research services; scientific research, namely, conducting clinical research trials; research and development of medicines based on protein and peptide therapeutic applications; medical diagnostic services; biological DNA cloning services; protein expression services in the field of biotechnology, namely, DNA gene cloning services, purification process development; laboratory services relating to the production of monoclonal antibodies; medical and scientific research services, namely, monoclonal antibody development, generation and screening and design related thereto
  • PM0001: AT GEN GLOBAL
Case File Event Statements
  • 9/24/2019 - 5 years ago
    8 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 9/24/2019 - 5 years ago
    7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 2/26/2019 - 5 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/26/2019 - 5 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/26/2019 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/14/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/30/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 11/15/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP